The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A RB-1 loss of function gene-signature (RBsig) as a tool to predict response to neoadjuvant chemotherapy (CT) plus anti-HER2 agents (H): A substudy of the NeoALTTO trial (BIG 1-06).
 
Emanuela Risi
No Relationships to Disclose
 
Chiara Biagioni
No Relationships to Disclose
 
Matteo Benelli
No Relationships to Disclose
 
Ilenia Migliaccio
No Relationships to Disclose
 
Amelia McCartney
No Relationships to Disclose
 
Martina Bonechi
No Relationships to Disclose
 
Cristina Guarducci
No Relationships to Disclose
 
Florentine Hilbers
Research Funding - Genentech/Roche (Inst); Novartis (Inst); Pfizer (Inst)
 
Serena Di Cosimo
No Relationships to Disclose
 
Jose Baselga
Leadership - Infinity Pharmaceuticals; Varian Medical Systems
Stock and Other Ownership Interests - GRAIL; Infinity Pharmaceuticals; Juno Therapeutics; PMV Pharma; Varian Medical Systems
Consulting or Advisory Role - GRAIL; Lilly; Novartis
 
Dario Romagnoli
No Relationships to Disclose
 
Giulia Boccalini
No Relationships to Disclose
 
Stefania Vitale
No Relationships to Disclose
 
Andrea Grilli
No Relationships to Disclose
 
Silvio Bicciato
No Relationships to Disclose
 
Christos Sotiriou
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; CEPHEID; Vertex
Speakers' Bureau - Eisai; Foundation Medicine; Prime Oncology; Teva
Travel, Accommodations, Expenses - Roche; Roche/Genentech
 
Laura Biganzoli
No Relationships to Disclose
 
Angelo Di Leo
Honoraria - AstraZeneca; Bayer; Celgene; Eisai; Genomic Health; Lilly; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Celgene; Daiichi Sankyo; Ipsen; Lilly; Novartis; Pfizer; Pierre Fabre; Puma Biotechnology; Roche
Research Funding - AstraZeneca; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Celgene; Daiichi Sankyo; Eisai; Lilly; Novartis; Pfizer; Pierre Fabre; Puma Biotechnology; Roche
 
Luca Malorni
Honoraria - AstraZeneca; Pfizer
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Pfizer
Travel, Accommodations, Expenses - Janssen; Roche